Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.

PloS one - 1 Jan 2012

Wei Hua, Kamat Ashish M, Aldousari Saad, Ye Yuanqing, Huang Maosheng, Dinney Colin P, Wu Xifeng

Abstract excerpt

Bladder cancer is the fifth most common cancer in the United States, and identifying genetic markers that may predict susceptibility in high-risk population is always needed. The purpose of our study is to determine whether genetic variations in the transforming growth factor-beta (TGF-β) pathway are associated with bladder cancer risk. We identified 356 single-nucleotide polymorphisms (SNPs) in 37 key genes from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Demography
Share to Epistasis, Genetic
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Survival Analysis

Share to Transforming Growth Factor beta

Share to Urinary Bladder Neoplasms

Share to Vascular Endothelial Growth Factor C

Source

Open in PubMed Open full text

Identifiers

PMID: 23251617
DOI: 10.1371/journal.pone.0051758
PMCID: PMC3520916

Genes

VEGFC
EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.PMID 23251617Read ↗

TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.Semantic proximity Read ↗

EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.Semantic proximity Read ↗

Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.Semantic proximity Read ↗

Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.Semantic proximity Read ↗

c.29C>T polymorphism in the transforming growth factor-β1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.Semantic proximity Read ↗

Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.Semantic proximity Read ↗

Molecular profiling of bladder cancer: Involvement of the TGF-β pathway in bladder cancer progressionSemantic proximity Read ↗

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.Semantic proximity Read ↗

Genome-wide association study identifies multiple loci associated with bladder cancer risk.Semantic proximity Read ↗

A systematic review of genome-wide association studies on bladder cancerSemantic proximity Read ↗

Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.Semantic proximity Read ↗

A systematic review of genome-wide association studies on bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.